Help
RSS
API
Feed
Maltego
Contact
Domain > reneopharma.com
×
Welcome!
Right click nodes and scroll the mouse to navigate the graph.
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2020-09-02
35.185.204.220
(
ClassC
)
2024-08-31
141.193.213.11
(
ClassC
)
2024-09-13
141.193.213.10
(
ClassC
)
2025-01-03
3.33.251.168
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 26 Aug 2023 20:41:24 GMTContent-Type: text/htmlContent-Length: 162Connection: keep-aliveLocation: https://reneopharma.com/X-WPE-Request-ID: ffd8b70fb8fe8576905 html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>nginx/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 26 Aug 2023 20:41:24 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveVary: Accept-EncodingVary: Accept-EncodingVary: Accept-EncodingVa !DOCTYPE html>html langen-US>head> meta charsetUTF-8> meta nameviewport contentwidthdevice-width, initial-scale1.0, viewport-fitcover /> meta namerobots contentindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1 />!-- Google Tag Manager for WordPress by gtm4wp.com -->script data-cfasyncfalse data-pagespeed-no-defer> var gtm4wp_datalayer_name dataLayer; var dataLayer dataLayer || ;/script>!-- End Google Tag Manager for WordPress by gtm4wp.com --> !-- This site is optimized with the Yoast SEO plugin v21.0 - https://yoast.com/wordpress/plugins/seo/ --> title>Home - Reneopharma/title> link relcanonical hrefhttps://reneopharma.com/ /> meta propertyog:locale contenten_US /> meta propertyog:type contentwebsite /> meta propertyog:title contentHome - Reneopharma /> meta propertyog:description contentMoving Medicines to Move People Reneo is focused on improving the lives of patients with rare genetic mitochondrial diseases. Learn More Our priority is to develop therapies to improve daily function and quality of life of patients living with these rare diseases. Learn More Reneo’s lead product candidate, mavodelpar (REN001), is known to control a… Continue reading Home /> meta propertyog:url contenthttps://reneopharma.com/ /> meta propertyog:site_name contentReneopharma /> meta propertyarticle:modified_time content2023-06-02T07:31:27+00:00 /> meta propertyog:image contenthttps://reneopharma.com/wp-content/uploads/2021/03/devreneonew.jpg /> meta nametwitter:card contentsummary_large_image /> script typeapplication/ld+json classyoast-schema-graph>{@context:https://schema.org,@graph:{@type:WebPage,@id:https://reneopharma.com/,url:https://reneopharma.com/,name:Home - Reneopharma,isPartOf:{@id:https://reneopharma.com/#website},about:{@id:https://reneopharma.com/#organization},primaryImageOfPage:{@id:https://reneopharma.com/#primaryimage},image:{@id:https://reneopharma.com/#primaryimage},thumbnailUrl:https://reneopharma.com/wp-content/uploads/2021/03/devreneonew.jpg,datePublished:2021-02-10T09:
Subdomains
Date
Domain
IP
www.reneopharma.com
2024-08-06
141.193.213.11
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]